Please provide your email address to receive an email when new articles are posted on . The introduction of long-acting injectable cabotegravir PrEP in sub-Saharan Africa could result in fewer future ...
Introduction Integration of management of tuberculosis (TB) and HIV with prevention and treatment of non-communicable ...
A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability that could lead to new therapies and bring the world closer to a ...
Many HIV-serodiscordant couples desire children and physician-assisted techniques can help individuals achieve pregnancy while reducing the risk of seroconversion in their seronegative partner. For ...
Kenya officially announced the introduction of a groundbreaking long-acting injectable HIV prevention drug, Lenacapavir, ...
ZIMBABWE has officially launched the long-acting HIV prevention injection lenacapavir, with the United States pledging to support access to the breakthrough drug for about 271,000 people over the next ...
HIV drug resistance can happen if the HIV virus in your body changes form, or mutates. This will affect how well your antiretroviral therapy (ART) works. Medications that are used to control your HIV ...
In his 2019 State of the Union address, President Donald Trump pledged to boost HIV spending, with the lofty goal of bringing the nation’s epidemic to heel by 2030. Last year, this federal initiative, ...
Zimbabwe is one of the world's first countries to roll out lenacapavir, a long-acting HIV prevention drug that is administered only twice a year. It offers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results